Transcriptional/JJ
activity/NN
of/IN
core/NN
binding/NN
factor-alpha/NN
(/(
AML1/NN
)/)
and/CC
beta/NN
subunits/NNS
on/IN
murine/JJ
leukemia/NN
virus/NN
enhancer/NN
cores/NNS
./.

Core/NN
binding/NN
factor/NN
(/(
CBF/NN
)/)
,/,
also/RB
known/VBN
as/IN
polyomavirus/NN
enhancer-binding/JJ
protein/NN
2/CD
and/CC
SL3/NN
enhancer/NN
factor/NN
1/CD
,/,
is/VBZ
a/DT
mammalian/JJ
transcription/NN
factor/NN
that/WDT
binds/VBZ
to/TO
an/DT
element/NN
termed/VBN
the/DT
core/NN
within/IN
the/DT
enhancers/NNS
of/IN
the/DT
murine/JJ
leukemia/NN
virus/NN
family/NN
of/IN
retroviruses/NNS
./.
=====
The/DT
core/NN
elements/NNS
of/IN
the/DT
SL3/NN
virus/NN
are/VBP
important/JJ
genetic/JJ
determinants/NNS
of/IN
the/DT
ability/NN
of/IN
this/DT
virus/NN
to/TO
induce/VB
T-cell/NN
lymphomas/NNS
and/CC
the/DT
transcriptional/JJ
activity/NN
of/IN
the/DT
viral/JJ
long/JJ
terminal/JJ
repeat/NN
in/IN
T/NN
lymphocytes/NNS
./.
=====
CBF/NN
consists/VBZ
of/IN
two/CD
subunits/NNS
,/,
a/DT
DNA/NN
binding/NN
subunit/NN
,/,
CBF/NN
alpha/NN
,/,
and/CC
a/DT
second/JJ
subunit/NN
,/,
CBF/NN
beta/NN
,/,
that/WDT
stimulates/VBZ
the/DT
DNA/NN
binding/NN
activity/NN
of/IN
CBF/NN
alpha/NN
./.
=====
One/CD
of/IN
the/DT
genes/NNS
that/WDT
encodes/VBZ
a/DT
CBF/NN
alpha/NN
subunit/NN
is/VBZ
AML1/NN
,/,
also/RB
called/VBN
Cbf/NN
alpha/NN
2/CD
./.
=====
This/DT
locus/NN
is/VBZ
rearranged/VBN
by/IN
chromosomal/JJ
translocations/NNS
in/IN
human/JJ
myeloproliferative/JJ
disorders/NNS
and/CC
leukemias/NNS
./.
=====
An/DT
exogenously/RB
expressed/VBN
Cbf/NN
alpha/NN
2-encoded/JJ
subunit/NN
(/(
CBF/NN
alpha/NN
2-451/CD
)/)
stimulated/VBD
transcription/NN
from/IN
the/DT
SL3/NN
enhancer/NN
in/IN
P19/NN
and/CC
HeLa/NN
cells/NNS
./.
=====
Activity/NN
was/VBD
mediated/VBN
through/IN
the/DT
core/NN
elements/NNS
./.
=====
Three/CD
different/JJ
isoforms/NNS
of/IN
CBF/NN
beta/NN
were/VBD
also/RB
tested/VBN
for/IN
transcriptional/JJ
activity/NN
on/IN
the/DT
SL3/NN
enhancer/NN
./.
=====
The/DT
longest/JJS
form/NN
,/,
CBF/NN
beta-187/NN
,/,
increased/VBD
the/DT
transcriptional/JJ
stimulation/NN
by/IN
CBF/NN
alpha/NN
2-451/CD
twofold/JJ
in/IN
HeLa/NN
cells/NNS
,/,
although/IN
it/PRP
had/VBD
no/DT
effect/NN
in/IN
P19/NN
cells/NNS
./.
=====
Transcriptional/JJ
activation/NN
by/IN
CBF/NN
beta/NN
required/VBD
binding/NN
to/TO
the/DT
CBF/NN
alpha/NN
subunit/NN
,/,
as/IN
a/DT
form/NN
of/IN
CBF/NN
beta/NN
that/WDT
lacked/VBD
binding/NN
ability/NN
,/,
CBF/NN
beta-148/NN
,/,
failed/VBD
to/TO
increase/VB
activity/NN
./.
=====
These/DT
results/NNS
indicated/VBD
that/IN
at/IN
least/JJS
in/IN
certain/JJ
cell/NN
types/NNS
,/,
the/DT
maximum/NN
activity/NN
of/IN
CBF/NN
required/VBD
both/DT
subunits/NNS
./.
=====
They/PRP
also/RB
provided/VBD
support/NN
for/IN
the/DT
hypothesis/NN
that/IN
CBF/NN
is/VBZ
a/DT
factor/NN
in/IN
T/NN
lymphocytes/NNS
that/WDT
is/VBZ
responsible/JJ
for/IN
recognition/NN
of/IN
the/DT
SL3/NN
cores/NNS
./.
=====
We/PRP
also/RB
examined/VBD
whether/IN
CBF/NN
could/MD
distinguish/VB
a/DT
1-bp/JJ
difference/NN
between/IN
the/DT
enhancer/NN
core/NN
of/IN
SL3/NN
and/CC
the/DT
core/NN
of/IN
the/DT
nonleukemogenic/JJ
virus/NN
,/,
Akv/NN
./.
=====
This/DT
difference/NN
strongly/RB
affects/VBZ
transcription/NN
in/IN
T/NN
cells/NNS
and/CC
leukemogenicity/NN
of/IN
SL3/NN
./.
=====
However/RB
,/,
no/DT
combination/NN
of/IN
CBF/NN
alpha/NN
and/CC
CBF/NN
beta/NN
subunits/NNS
that/WDT
we/PRP
tested/VBD
was/VBD
able/JJ
to/TO
distinguish/VB
the/DT
1-bp/JJ
difference/NN
in/IN
transcription/NN
assays/NNS
./.
=====
Thus/RB
,/,
a/DT
complete/JJ
understanding/NN
of/IN
how/WRB
T/NN
cells/NNS
recognize/VBP
the/DT
SL3/NN
core/NN
remains/VBZ
to/TO
be/VB
elucidated/VBN
./.